Keros Therapeutics, Inc. (KROS) Free Cash Flow
Keros Therapeutics, Inc. (KROS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2020-12-31 | -$37.19M |
| 2021-12-31 | -$63.17M |
| 2022-12-31 | -$71.30M |
| 2023-12-31 | -$126.97M |
| 2024-12-31 | -$162.80M |
| 2025-12-31 | $105.95M |
How KROS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ATRC | AtriCure Inc. | $48.28M |
| VREX | Varex Imaging Corporation | $18.80M |
| MNKD | MannKind Corporation | $13.69M |
| HBIO | Harvard Bioscience Inc. | $4.87M |
| CERS | Cerus Corporation | $1.11M |
These are five companies in the same sector as KROS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Keros Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("KROS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KROS | $11.12 | -4.79% | 0.11M |
| 3 | ||||
| 4 | ||||
| 5 |